Supplementary
: Effects of everolimus, Ku0063794, and their combination on the expression of EMT-related proteins in HCC cells. EMT-related proteins include matrix metalloproteinase-2 (MMP-2), tissue inhibitor of matrix metalloproteinase-1 (TIMP-1), and α-smooth muscle actin (α-SMA). Higher expression of these proteins correlates with EMT, and lower expression of these proteins correlates with the reversal of EMT. We further investigated the effects of everolimus, Ku0063794, and their combination on the expression of these EMT-related proteins in HCC cells. Although individual monotherapies showed variable expression of these proteins, the combination therapy consistently reduced the expression of these proteins in a dose-dependent manner in HepG2 (A), Hep3B (B), and Huh7 (C) cells. Each data point represents the mean ± SD of three independent experiments. [Left] Relative densities of these markers which were quantified using Image J software. The combination therapy significantly inhibited EMT, which was manifested by higher expression of E-cadherin and lower expression of Snail; however, it could not inhibit EMT in SIRT1-overexpressing HepG2 cells. These results also indicate that the combination therapy inhibits EMT of Hep3B cells by way of inhibiting SIRT1. Each data point represents the mean ± SD of three independent experiments. *P < 0.05 vs. control.

